Discussions

Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or composed of living entities such as cells and tissues, which include a wide range of products such as vaccines, blood and blood components, allergenics, somatic cells, gene therapy, tissues, and recombinant therapeutic proteins1. With the emergence of biosimilars, antibody drug conjugates (ADC) and biobetters, the scope of biopharmaceutical treatment has become more widespread. As early as 2014, the market value of biopharmaceuticals has exceeded $150 billion2. As one of the fastest growing scientific fields, biopharmaceutical requirements for characterization techniques are even more prominent. In contrast to small molecule drugs, small variations of biologic molecules may lead to a strong impact on the final biological properties (including the product's performance, ability to be processed, stability and appearance) and treatment efficacy. Therefore, adequate characterization of biopharmaceuticals is essential for candidate products to be developed and approved for marketing.

Biopharmaceutical experts from Alfa Chemistry have a great deal of experience in researching many kinds of biologics such as large, complex molecules and mixture of molecules. To ensure the safety, efficacy, quality, purity and potency of your biopharmaceutical products, our experienced experts can work with you to investigate the composition of your drug product or substance. With various advanced analysis methods, our experts strategically address the key molecular and biological characteristics to ensure the high quality of your specific products. Check more details about biopharmaceutical characterization services.